The U.S. Food and Drug Administration has cleared a new artificial intelligence system that detects pneumothorax on x-rays and quickly alerts radiologists.
London-based imaging tech company Behold.ai received the green-light for its red dot “instant triage” platform, the company announced late last week. It also said users will be charged on a per-exam basis, with plans to release the platform in the U.S. later this year.
Additionally, Behold.ai said highly experience radiologists helped train the technology and three board-certified radiologists validated the approach against more than 800 cases in the U.K and U.S.
“We are delighted to have received clearance for our algorithm in the U.S.,” Simon Rasalingham, chief executive of Behold.ai, said in the announcement. “FDA clearance is not just about safety but also about efficacy. We believe our technology can make a big difference to patient safety, the delivery of care and cost savings to the system.”